Overview on pathophysiology and newer approaches to treatment of peripheral neuropathies.
Peripheral neuropathies are extremely heterogeneous nosological entities. One of the most common symptoms is pain, the underlying mechanisms of which are numerous and complex. Inflammation, reparative processes, and anatomical and gene expression alterations lead to chronic pain, the persistence of which is sustained by peripheral and central sensitisation mechanisms. Treatment of peripheral neuropathies is targeted to its symptomatic and aetiological features. For pain relief, several types of drugs may be used, notably antidepressants (e.g. tricyclic antidepressants, selective serotonin reuptake inhibitors, and both serotonin and noradrenaline [norepinephrine] reuptake inhibitors), antiepileptic drugs (e.g. carbamazepine, phenytoin, lamotrigine, valproic acid, gabapentin, topiramate and pregabalin), NSAIDs and opioid analgesics. Aetiological therapy is aimed at modifying the pathophysiological mechanisms underlying the neuropathy, some of which are common in different neuropathic conditions. Certain drugs are known to exert more than one action on different pathophysiological mechanisms. This is the case with acetyl-L-carnitine (ALC), which can be considered both a symptomatic therapy that can be used in any kind of painful neuropathy, and an aetiological therapy, at least in diabetic neuropathy and neuropathies induced by nucleoside reverse transcriptase inhibitors and cancer chemotherapeutic agents. ALC acts via several mechanisms, inducing regeneration of injured nerve fibres, reducing oxidative stress, supporting DNA synthesis in mitochondria, and enhancing nerve growth factor concentrations in neurons.
Vanotti
Alessandra
A
U.O. Neurologia, Ospedale Luigi Sacco, Milan, Italy.
Osio
Maurizio
M
Mailland
Enrico
E
Nascimbene
Caterina
C
Capiluppi
Elisa
E
Mariani
Claudio
C
D000108:Acetylcarnitine / Q000627:therapeutic use*; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D018697:Nootropic Agents / Q000627:therapeutic use*; D010146:Pain / Q000209:etiology; D010523:Peripheral Nervous System Diseases / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use
D000701:Analgesics, Opioid; D000927:Anticonvulsants; D000928:Antidepressive Agents; D000970:Antineoplastic Agents; D018697:Nootropic Agents; D018894:Reverse Transcriptase Inhibitors; D000108:Acetylcarnitine
Br J Pharmacol. 1997 Aug;121(8):1513-22
9283683
Neurology. 2003 Apr 22;60(8):1284-9
12707430
Eur J Cancer. 2005 Aug;41(12):1746-50
16039110
Muscle Nerve. 2004 Jul;30(1):3-19
15221874
Mol Pain. 2006 Jun 09;2:20
16764720
JAMA. 1998 Dec 2;280(21):1837-42
9846778
Clin Ther. 2003 Oct;25(10):2506-38
14667954
Pain. 2004 Aug;110(3):628-38
15288403
Neurology. 1998 Jun;50(6):1842-6
9633738
Tumori. 2005 Mar-Apr;91(2):135-8
15948540
Int J Clin Pharmacol Res. 1992;12(5-6):269-79
1338731
Mol Pharmacol. 2002 May;61(5):989-96
11961116
AIDS. 2004 Jul 23;18(11):1549-60
15238773
Pain Med. 2005 Sep-Oct;6(5):346-56
16266355
Diabetes Care. 2005 Jan;28(1):89-94
15616239
Neurology. 2004 Dec 14;63(11):2104-10
15596757
Pain. 1999 Oct;83(1):85-90
10506675
HIV Clin Trials. 2005 Nov-Dec;6(6):344-50
16566084
Pharmacol Ther. 2000 Nov;88(2):163-85
11150596
Diabetes Care. 2003 May;26(5):1553-79
12716821
Drugs R D. 2002;3(4):223-31
12455197
Pain. 2004 Aug;110(3):697-706
15288411
Pain. 2005 Jul;116(1-2):109-18
15927394
Pharmacol Rep. 2006 Jan-Feb;58(1):1-12
16531624
Clin J Pain. 2006 Oct;22(8):692-9
16988565
Am J Pathol. 2003 Nov;163(5):1703-6
14578168
Arch Neurol. 2003 Nov;60(11):1524-34
14623723
Neurology. 2001 May 22;56(10):1371-7
11376190
Pain Med. 2005 May-Jun;6(3):225-34
15972086
Neurosci Lett. 2002 Mar 1;320(1-2):99-101
11849773
Clin Cancer Res. 2003 Nov 15;9(15):5756-67
14654561
Mini Rev Med Chem. 2003 Nov;3(7):729-48
14529514
Pharmacotherapy. 2001 Sep;21(9):1070-81
11560197
Naunyn Schmiedebergs Arch Pharmacol. 2005 Aug;372(2):107-14
16217643
J Peripher Nerv Syst. 2002 Mar;7(1):28-36
11939349
Ann N Y Acad Sci. 2001 Mar;933:157-74
12000018
AIDS. 1997 Jan;11(1):19-26
9110071
Pain. 2001 Nov;94(2):215-24
11690735
AIDS. 1997 Feb;11(2):185-90
9030365
HIV Med. 2007 May;8(4):241-50
17461852
J Pain Symptom Manage. 2004 Feb;27(2):133-9
15157037
Anticancer Res. 2005 Jul-Aug;25(4):2681-7
16080512
CNS Spectr. 2005 Apr;10(4):285-97
15902759
Pain. 2003 Jul;104(1-2):323-31
12855342
J Pain. 2005 Apr;6(4):253-60
15820913
Curr Diab Rep. 2003 Dec;3(6):459-67
14611741
Diabet Med. 2001 Mar;18(3):185-92
11318838
J Peripher Nerv Syst. 2006 Mar;11(1):72-6
16519785
Anaesthesia. 2002 May;57(5):451-62
11966555